Literature DB >> 6647

The absorption and elimination of metoclopramide in three animal species.

O M Bakke, J Segura.   

Abstract

The absorption and elimination of metoclopramide have been studied in the rat, rabbit and dog. Thin-layer chromatography followed by photodensitometry was used for the analysis of the unchanged drug and its metabolites. N-De-ethylation is an important Phase I metabolic reaction and conjugation with glucoronic acid and sulphate is a major route of metabolism, particularly in the rabbit. The pharmacokinetic parameters after intravenous administration showed little interspecies variation. First order elimination kinetics with short half-lives and high apparent volumes of distribution (greater than 1.1 kg(-1)) were observed. Major interspecies variations were seen after oral administration of high doses of the drug. Metoclopramide was eliminated slowly after oral administration to rats. The findings in the rabbit and in the dog suggest that the liver plays an active role reducing the systemic availability of unchanged metoclopramide after oral administration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6647     DOI: 10.1111/j.2042-7158.1976.tb04019.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Single-dose pharmacokinetics of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; W D Hooper; F Bochner
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

Review 3.  Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Authors:  J G Hatlebakk; A Berstad
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

4.  Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.

Authors:  D N Bateman; C Kahn; K Mashiter; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

5.  Identification of metoclopramide metabolites in the urine of cattle by gas chromatography-mass spectrometry and high-performance liquid chromatography-photodiode array detection.

Authors:  R D Jones; C D Blanton; J M Bowen
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

Review 6.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of metoclopramide.

Authors:  D N Bateman
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

8.  High pressure liquid chromatographic analysis of metoclopramide in serum.

Authors:  J L Cohen; G H Hisayasu; S B Strum
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

Review 9.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

10.  The effects of oral administration of Cola nitida on the pharmacokinetic profile of metoclopramide in rabbits.

Authors:  Cecilia Nwadiuto Amadi; Wisdom Izuchukwu Nwachukwu
Journal:  BMC Pharmacol Toxicol       Date:  2020-01-06       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.